Table 3 Coronary calcium score, number and volume of coronary plaques in SLE patients from the placebo group and atorvastatin group at randomization and after one year of treatment
| Â | At randomization | After one year | P |
|---|---|---|---|
Placebo group, n = 32 | |||
Number of patients with plaques | 9 (28.1%) | 10 (31.3%) | ns |
Plaque volume (mm3) | 35.2 ± 44.9 | 62.9 ± 72.4 | < 0.05 |
Number of plaques | 2-13 (median 4) | 1-12 (median 5) | ns |
Calcium score | 32.1 ± 39.1 | 59.5 ± 54.4 | < 0.05 |
Atorvastatin group, n = 28 | |||
Number of patients with plaques | 6 (21.4%) | 6 (21.4%) | ns |
Plaque volume (mm3) | 54.5 ± 62.4 | 51.0 ± 47.6 | ns |
Number of plaques | 2-4 (median 2) | 1-8 (median 2) | ns |
Calcium score | 44.8 ± 50.6 | 54.9 ± 62.5 | ns |